44
Participants
Start Date
November 20, 2021
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Alendronate
On time Zoledronate: Zoledronate would be given (one dose for one year) after the completiong of denosumab on time Alendronate and Zoledronate: Alendronate would be given one month before the the completiong of denosumab and the following 3 months (Total four months). After the completion of Alendronate, Zoledronate would be given (one dose).
RECRUITING
National Taiwan University Hospital, Yunlin branch, Douliu
National Taiwan University Hospital
OTHER